+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Head And Neck Cancer Drug"

Head & Neck Cancer Drugs Market by Product, Drug Class, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Head & Neck Cancer Drugs Market by Product, Drug Class, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 199 Pages
  • Global
From
Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (Chemotherapy, Immunotherapy), By Route Of Administration (Injectable, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 - Product Thumbnail Image

Head And Neck Cancer Therapeutics Market Size, Share & Trends Analysis Report By Therapy Type (Chemotherapy, Immunotherapy), By Route Of Administration (Injectable, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • July 2024
  • 150 Pages
  • Global
From
Head and Neck Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Head and Neck Cancer Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 93 Pages
  • Global
From
Head and Neck Cancer Therapeutics Market Report 2025 - Product Thumbnail Image

Head and Neck Cancer Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Head and Neck Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Head and Neck Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 134 Pages
  • Global
From
Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Head and Neck Cancer Treatment Market 2024-2028 - Product Thumbnail Image

Head and Neck Cancer Treatment Market 2024-2028

  • Report
  • June 2024
  • 165 Pages
  • Global
From
Head and Neck Cancer Therapeutics - A Global Market Overview - Product Thumbnail Image

Head and Neck Cancer Therapeutics - A Global Market Overview

  • Report
  • November 2024
  • 301 Pages
  • Global
From
Recurrent or Metastatic Head and Neck cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Recurrent or Metastatic Head and Neck cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
PD-1 Resistant Head and Neck Cancer (HNC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

PD-1 Resistant Head and Neck Cancer (HNC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Metastatic Head and Neck Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Head and Neck Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Radiation induced-Oral Mucositis (RIOM) in Head and neck Cancer (HNC) - Pipeline Insight, 2024 - Product Thumbnail Image

Radiation induced-Oral Mucositis (RIOM) in Head and neck Cancer (HNC) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Recurrent Or Metastatic Head And Neck Cancer Market - Product Thumbnail Image

Recurrent Or Metastatic Head And Neck Cancer Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • January 2025
  • 180 Pages
  • Global
From
Cancer Immunotherapy Market Report 2024-2034 - Product Thumbnail Image

Cancer Immunotherapy Market Report 2024-2034

  • Report
  • June 2024
  • 286 Pages
  • Global
From
Particle Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Proton Therapy, Heavy Ion Therapy), System, Application (Treatment, Research), Cancer Type (Pediatric, Breast, Lung), Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Particle Therapy Market Size, Share & Trends Analysis Report by Therapy Type (Proton Therapy, Heavy Ion Therapy), System, Application (Treatment, Research), Cancer Type (Pediatric, Breast, Lung), Region, and Segment Forecasts, 2024-2030

  • Report
  • June 2024
  • 150 Pages
  • Global
From
Cancer Immunotherapy Market Report by Therapy Type, Application, End User, and Region 2024-2032 - Product Thumbnail Image

Cancer Immunotherapy Market Report by Therapy Type, Application, End User, and Region 2024-2032

  • Report
  • July 2024
  • 143 Pages
  • Global
From
Head and Neck Cancer (HNC) Pipeline Analysis Report - Product Thumbnail Image

Head and Neck Cancer (HNC) Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • May 2024
  • 184 Pages
  • Global
From
Loading Indicator

The Head and Neck Cancer Drug market is a subset of the larger Oncology Drugs market. It includes drugs used to treat cancers of the head and neck, such as squamous cell carcinoma, salivary gland cancer, and nasopharyngeal cancer. These drugs are typically used in combination with radiation therapy and/or surgery to treat the cancer. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and monoclonal antibodies. The Head and Neck Cancer Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Roche. Other companies include Novartis, Eli Lilly, and GlaxoSmithKline. Show Less Read more